Hairy Cell Leukemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Condition: Leukemia, Hairy CellInterventions: Drug: moxetumomab pasudotox; Drug: IV Bag Protectant for Moxetumomab pasudtoxSponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)Recruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2013 Category: Research Source Type: clinical trials
Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Condition: Leukemia, Hairy CellInterventions: Drug: moxetumomab pasudotox; Drug: IV Bag Protectant for Moxetumomab pasudtoxSponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)Recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2013 Category: Research Source Type: clinical trials
Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Condition: Leukemia, Hairy CellInterventions: Drug: moxetumomab pasudotox; Drug: IV Bag Protectant for Moxetumomab pasudotoxSponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)Recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2013 Category: Research Source Type: clinical trials
Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Condition: Leukemia, Hairy CellInterventions: Drug: moxetumomab pasudotox; Drug: IV Bag Protectant for Moxetumomab pasudotoxSponsor: MedImmune LLCRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2013 Category: Research Source Type: clinical trials
Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Condition: Leukemia, Hairy CellInterventions: Drug: moxetumomab pasudotox; Drug: IV Bag Protectant for Moxetumomab pasudtoxSponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)Recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2013 Category: Research Source Type: clinical trials
Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Condition: Leukemia, Hairy CellInterventions: Drug: moxetumomab pasudotox; Drug: IV Bag Protectant for Moxetumomab pasudotoxSponsor: MedImmune LLCRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2013 Category: Research Source Type: clinical trials
Ipilimumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; Extrano...
Source: ClinicalTrials.gov - April 1, 2013 Category: Research Source Type: clinical trials
